Publications
- Tolerability and Safety of the New Anti-Obesity Medications2014 | Third Faculty of Medicine
- Treatment Options for Children with Monogenic Forms of Obesity2013 | Third Faculty of Medicine, Second Faculty of Medicine
- Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks2011 | Third Faculty of Medicine
- Regulation of energy balance and eating behaviour2023 | Third Faculty of Medicine, Second Faculty of Medicine
- Current pharmacotherapy options in pediatric obesity2023 | Third Faculty of Medicine, Second Faculty of Medicine
- Dual agonist of incretin receptors: a novel antidiabetic drug is promising obesity therapeutic prospect2022 | Third Faculty of Medicine
- Základy klinické obezitologie2021 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Melanocortin Pathways: Suppressed and Stimulated Melanocortin-4 Receptor (MC4R)2020 | Third Faculty of Medicine
- Over 20 years with orexins2020 | Third Faculty of Medicine
- Etiopathogenesis of childhood obesity2019 | Third Faculty of Medicine
Loading network view...